| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |